European tech funding raised by Switzerland startups during Q2 2016.
In Q2 2016, 26 startups in Switzerland raised a combined €190M across 26 funding rounds, up 104.7% versus Q2 2015. Healthtech was the most active sector, and Polytech Ecosystem Venture was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| AC Immune | Series D+ | May 2016 | €40M |
| Nexthink | Series D+ | Apr 2016 | €35M |
| CRISPR Therapeutics | Series B | Jun 2016 | €35M |
| Aleva Neurotherapeutics | Series C |
| Acquisition |
| Jun 2016 |
| €845M |
| EngMab | Acquisition | May 2016 | €545M |
| May 2016 |
| €16M |
| Nouscom | Series A | May 2016 | €12M |
| Biovotion | Series A | Jun 2016 | €9.0M |
| WayRay | Early VC | Jun 2016 | €8.2M |
| Anergis | Series C | Apr 2016 | €4.6M |
| Beekeeper | Early VC | Apr 2016 | €4.4M |
| Gamaya | Series A | May 2016 | €3.0M |
| Polyneuron Pharmaceuticals | Seed | May 2016 | €2.7M |
| DEPSys | Series A | Jun 2016 | €2.7M |
| beqom | Early VC | Apr 2016 | €2.6M |
| Relief Therapeutics | Series A | May 2016 | €2.5M |
| GenView | Series A | Jun 2016 | €2.0M |
